Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.38 - $12.5 $17,646 - $21,250
-1,700 Reduced 60.71%
1,100 $13,000
Q1 2024

May 15, 2024

BUY
$8.04 - $12.29 $22,511 - $34,412
2,800 New
2,800 $31,000
Q3 2023

Nov 14, 2023

BUY
$6.86 - $8.18 $2,058 - $2,454
300 New
300 $2,000
Q1 2023

May 15, 2023

SELL
$4.36 - $6.15 $12,644 - $17,835
-2,900 Reduced 9.97%
26,200 $159,000
Q4 2022

Feb 14, 2023

BUY
$3.99 - $4.95 $19,152 - $23,760
4,800 Added 19.75%
29,100 $126,000
Q3 2022

Nov 14, 2022

SELL
$0.75 - $5.95 $3,750 - $29,750
-5,000 Reduced 17.06%
24,300 $95,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.27B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.